# Alpha-bisabolol for Onychomycosis Treatment

> **NCT04940520** · PHASE1 · COMPLETED · sponsor: **Universidade do Vale do Sapucai** · enrollment: 60 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **BIOLOGICAL:** Drug recommended by the Brazilian Society of Dermatology
- **COMBINATION_PRODUCT:** Alpha bisabolol product and laser
- **BIOLOGICAL:** Alpha bisabolol product

## Key facts

- **NCT ID:** NCT04940520
- **Lead sponsor:** Universidade do Vale do Sapucai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-05-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940520, "Alpha-bisabolol for Onychomycosis Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04940520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*